COMBINATION OF BEZAFIBRATE AND OF RESVERATROL OR RESVERATROL DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DISEASES INVOLVING A MITOCHONDRIAL ENERGY DYSFUNCTION
Institut National De La Santé Et De La Recherche Médicale (INSERM);Universite Paris Descartes
发明人:
Jean Bastin,Fatima Djouadi
申请号：
US15105116
公开号：
US20160317483A1
申请日:
2014.12.19
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to the combined use of bezafibrate and of resveratrol or resveratrol derivatives for the treatment of diseases involving a mitochondrial energy dysfunction, and also to a pharmaceutical kit comprising both bezafibrate and resveratrol or resveratrol derivatives. The combination is more particularly used in the treatment of moderate defects of β-oxidation of long-chain fatty acids or of the respiratory chain of mitochondria.
